NCT05441306

Brief Summary

This is a randomized pilot study to test the acceptance and use of PerHL among formerly incarcerated individuals

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
5mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 28, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 1, 2022

Completed
4.1 years until next milestone

Study Start

First participant enrolled

August 1, 2026

Expected
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

May 5, 2026

Status Verified

April 1, 2026

Enrollment Period

5 months

First QC Date

June 28, 2022

Last Update Submit

April 30, 2026

Conditions

Personal Health InformationIncarcerated Individuals

Outcome Measures

Primary Outcomes (4)

  • Acceptance - Intention to use

    Assess intention to use the app developed for the project. Intention to use will be assessed by a survey conducted in person. This survey item is in development.

    1 month post enrollment

  • Acceptance - Intention to use

    Assess intention to use the app developed for the project. Intention to use will be assessed by a survey conducted in person. This survey item is in development.

    3 month post enrollment

  • Use of Personal health information technology

    Assess the number of times the personal health information app was accessed each week and the duration of time on the system per week. This will be assessed using tracking functionality built into the app.

    1 month post enrollment

  • Use of Personal health information technology

    Assess the number of times the personal health information app was accessed each week and the duration of time on the system per week. This will be assessed using tracking functionality built into the app.

    3 month post enrollment

Secondary Outcomes (14)

  • Perceived ease of use for the app

    1 month post enrollment

  • Perceived ease of use for the app

    3 month post enrollment

  • Perceived usefulness of the app

    1 month post enrollment

  • Perceived usefulness of the app

    3 month post enrollment

  • Attitude towards use of technology

    1 month post enrollment

  • +9 more secondary outcomes

Study Arms (2)

Access to Personal Health Library (PerHL) + MyChart

EXPERIMENTAL

Participants randomized to the PerHL arm will have access to PerHL and the standard of care patient portal (Epic®MyChart).

Device: Personal Health Library (PerHL) + MyChart

Control - MyChart

ACTIVE COMPARATOR

Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart).

Device: Epic®MyChart

Interventions

Personal Health Library (PerHL) + MyChartDEVICE

Participants randomized to the PerHL arm will have access to PerHL + the standard of care patient portal (Epic®MyChart).

Access to Personal Health Library (PerHL) + MyChart
Epic®MyChartDEVICE

Participants randomized to the control arm will receive the standard of care patient portal (Epic®MyChart).

Control - MyChart

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • English-speaking
  • have at least one chronic condition
  • engaged in primary care in the community
  • have been released from a correctional facility in the past year.

You may not qualify if:

  • visual impairments
  • cognitive impairments
  • language barriers
  • planned relocation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yale School of Medicine

New Haven, Connecticut, 06510, United States

Location

Study Officials

  • Karen Wang, MD, MHS

    Yale University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Kimberly Vasquez, MPH

CONTACT

2123630809kimberly.vasquez@yale.edu

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 28, 2022

First Posted

July 1, 2022

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

May 5, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations

US(1)